Literature DB >> 19823189

Design of a family-based lifestyle intervention for youth with type 2 diabetes: the TODAY study.

.   

Abstract

Type 2 diabetes is associated with obesity and is increasing at an alarming rate in youth. Although weight loss through lifestyle change is one of the primary treatment recommendations for adults with type 2 diabetes, the efficacy of this approach has not been tested with youth. This paper provides a summary of the reviews and meta-analyses of pediatric weight-loss interventions that informed the design and implementation of an intensive, family-based lifestyle weight management program for adolescents with type 2 diabetes and their families developed for the Treatment Options for type 2 Diabetes in Adolescents and Youth (TODAY) study. A total of 1092 youth have been screened, and 704 families have been randomized for inclusion in this 15-center clinical trial sponsored by the National Institutes of Health. The TODAY study is designed to test three approaches (metformin, metformin plus rosiglitazone and metformin plus an intensive lifestyle intervention) to the treatment of a diverse cohort of youth, 10-17 years of age, within 2 years of their diagnosis. The principal goal of the TODAY Lifestyle Program (TLP) is to decrease baseline weight of youth by 7-10% (or the equivalent for children who are growing in height) through changes in eating and physical activity habits, and to sustain these changes through ongoing treatment contact. The TLP is implemented by interventionists called Personal Activity and Nutrition Leaders (PALs) and delivered to youth with type 2 diabetes, and at least one family support person. The TLP provides a model for taking a comprehensive, continuous care approach to the treatment of severe overweight in youth with comorbid medical conditions such as type 2 diabetes.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19823189      PMCID: PMC2822093          DOI: 10.1038/ijo.2009.195

Source DB:  PubMed          Journal:  Int J Obes (Lond)        ISSN: 0307-0565            Impact factor:   5.095


  57 in total

Review 1.  Energy expenditure, physical activity and body-weight control.

Authors:  L Tappy; C Binnert; Ph Schneiter
Journal:  Proc Nutr Soc       Date:  2003-08       Impact factor: 6.297

2.  Lifestyle interventions in the treatment of childhood overweight: a meta-analytic review of randomized controlled trials.

Authors:  Denise E Wilfley; Tiffany L Tibbs; Dorothy J Van Buren; Kelle P Reach; Mark S Walker; Leonard H Epstein
Journal:  Health Psychol       Date:  2007-09       Impact factor: 4.267

Review 3.  Pediatric obesity and insulin resistance: chronic disease risk and implications for treatment and prevention beyond body weight modification.

Authors:  M L Cruz; G Q Shaibi; M J Weigensberg; D Spruijt-Metz; G D C Ball; M I Goran
Journal:  Annu Rev Nutr       Date:  2005       Impact factor: 11.848

4.  Relapse prevention training and problem-solving therapy in the long-term management of obesity.

Authors:  M G Perri; A M Nezu; W F McKelvey; R L Shermer; D A Renjilian; B J Viegener
Journal:  J Consult Clin Psychol       Date:  2001-08

Review 5.  Behavioral therapy for obesity.

Authors:  D A Williamson; L A Perrin
Journal:  Endocrinol Metab Clin North Am       Date:  1996-12       Impact factor: 4.741

Review 6.  Importance of weight management in type 2 diabetes: review with meta-analysis of clinical studies.

Authors:  James W Anderson; Cyril W C Kendall; David J A Jenkins
Journal:  J Am Coll Nutr       Date:  2003-10       Impact factor: 3.169

Review 7.  Type 2 diabetes mellitus in children and youth: a new epidemic.

Authors:  Francine Ratner Kaufman
Journal:  J Pediatr Endocrinol Metab       Date:  2002-05       Impact factor: 1.634

Review 8.  Lifestyle modification in the treatment of obesity: an educational challenge and opportunity.

Authors:  L R Jones; C I Wilson; T A Wadden
Journal:  Clin Pharmacol Ther       Date:  2007-03-14       Impact factor: 6.875

9.  Parent weight change as a predictor of child weight change in family-based behavioral obesity treatment.

Authors:  Brian H Wrotniak; Leonard H Epstein; Rocco A Paluch; James N Roemmich
Journal:  Arch Pediatr Adolesc Med       Date:  2004-04

10.  Short- and long-term beneficial effects of a multidisciplinary therapy for the control of metabolic syndrome in obese adolescents.

Authors:  Danielle Arisa Caranti; Marco Túlio de Mello; Wagner L Prado; Lian Tock; Kãli O Siqueira; Aline de Piano; Mara C Lofrano; Dejaldo M J Cristofalo; Henrique Lederman; Sérgio Tufik; Ana R Dâmaso
Journal:  Metabolism       Date:  2007-09       Impact factor: 8.694

View more
  32 in total

Review 1.  The future of treating youth-onset type 2 diabetes: focusing upstream and extending our influence into community environments.

Authors:  Shazhan Amed
Journal:  Curr Diab Rep       Date:  2015-03       Impact factor: 4.810

2.  Weight change in the management of youth-onset type 2 diabetes: the TODAY clinical trial experience.

Authors:  M D Marcus; D E Wilfley; L El Ghormli; P Zeitler; B Linder; K Hirst; C E Ievers-Landis; D J van Buren; N Walders-Abramson
Journal:  Pediatr Obes       Date:  2016-05-10       Impact factor: 4.000

3.  Metabolic syndrome is common and persistent in youth-onset type 2 diabetes: Results from the TODAY clinical trial.

Authors:  Ruth S Weinstock; Kimberly L Drews; Sonia Caprio; Natasha I Leibel; Siripoom Vudhipoom McKay; Philip S Zeitler
Journal:  Obesity (Silver Spring)       Date:  2015-06-05       Impact factor: 5.002

4.  Self-reported dietary intake of youth with recent onset of type 2 diabetes: results from the TODAY study.

Authors:  Linda Delahanty; Andrea Kriska; Sharon Edelstein; Nancy Amodei; Jennifer Chadwick; Kenneth Copeland; Bryan Galvin; Laure El Ghormli; Morey Haymond; Megan M Kelsey; Chad Lassiter; Kerry Milaszewski; Amy Syme; Elizabeth Mayer-Davis
Journal:  J Acad Nutr Diet       Date:  2013-03       Impact factor: 4.910

5.  Adiposity, Hepatic Triglyceride, and Carotid Intima Media Thickness During Behavioral Weight Loss Treatment in Antipsychotic-Treated Youth: A Randomized Pilot Study.

Authors:  Ginger E Nicol; Rachel Kolko; Eric J Lenze; Michael D Yingling; J Philip Miller; Amanda R Ricchio; Julia A Schweiger; Robert L Findling; Denise Wilfley; John W Newcomer
Journal:  J Child Adolesc Psychopharmacol       Date:  2019-04-17       Impact factor: 2.576

6.  Metformin monotherapy in youth with recent onset type 2 diabetes: experience from the prerandomization run-in phase of the TODAY study.

Authors:  Lori Laffel; Nancy Chang; Margaret Grey; Dan Hale; Laurie Higgins; Kathryn Hirst; Roberto Izquierdo; Mary Larkin; Christina Macha; Trang Pham; Aimee Wauters; Ruth S Weinstock
Journal:  Pediatr Diabetes       Date:  2012-02-27       Impact factor: 4.866

7.  Drug resistance to inhibitors of the human double minute-2 E3 ligase is mediated by point mutations of p53, but can be overcome with the p53 targeting agent RITA.

Authors:  Richard J Jones; Chad C Bjorklund; Veerabhadran Baladandayuthapani; Deborah J Kuhn; Robert Z Orlowski
Journal:  Mol Cancer Ther       Date:  2012-08-28       Impact factor: 6.261

8.  Adherence to a lifestyle program for youth with type 2 diabetes and its association with treatment outcome in the TODAY clinical trial.

Authors:  Robert I Berkowitz; Marsha D Marcus; Barbara J Anderson; Linda Delahanty; Nisha Grover; Andrea Kriska; Lori Laffel; Amy Syme; Elizabeth Venditti; Dorothy J Van Buren; Denise E Wilfley; Patrice Yasuda; Kathryn Hirst
Journal:  Pediatr Diabetes       Date:  2017-06-30       Impact factor: 4.866

9.  Lipid Profiles, Inflammatory Markers, and Insulin Therapy in Youth with Type 2 Diabetes.

Authors:  Lorraine E Levitt Katz; Fida Bacha; Samuel S Gidding; Ruth S Weinstock; Laure El Ghormli; Ingrid Libman; Kristen J Nadeau; Kristin Porter; Santica Marcovina
Journal:  J Pediatr       Date:  2018-02-02       Impact factor: 4.406

10.  Parenting style, parent-youth conflict, and medication adherence in youth with type 2 diabetes participating in an intensive lifestyle change intervention.

Authors:  Ronald D Saletsky; Paula M Trief; Barbara J Anderson; Paula Rosenbaum; Ruth S Weinstock
Journal:  Fam Syst Health       Date:  2014-02-17       Impact factor: 1.950

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.